We are submitting the Company''s reply to queries raised by BSE Limited for the Corporate Announcement of the Company submitted on 2nd May 2025 pertaining to resignation of Mr. Sachin Mehta ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has responded to queries raised by BSE on its earlier corporate announcement dated May 2, 2025 about a change in Chief Financial Officer effective May 1, 2025. BSE had pointed out that the resignation letter of outgoing CFO Mr. Sachin Mehta was not enclosed with the original filing; the company says this was an unintentional oversight and has now submitted the letter dated April 23, 2025. Mr. Sachin Mehta will continue as Joint Managing Director of the company and is a relative of Mr. Hemal Mehta, Chairman & Managing Director. The newly appointed CFO, Mr. Manoj Lodha, is a Chartered Accountant, Cost Accountant and Law graduate with over 30 years of experience, including 25 years as President & CFO of Jain Irrigation Systems Limited.
This is a routine regulatory clarification with no change to the substance of the CFO transition already disclosed on May 2, 2025. Shareholders should see no material impact on the stock from this procedural correction.